Apollo Medical (NASDAQ:AMEH) Trading Down 6%

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) dropped 6% during trading on Tuesday . The company traded as low as $35.61 and last traded at $35.61. Approximately 48,227 shares were traded during mid-day trading, a decline of 71% from the average daily volume of 165,856 shares. The stock had previously closed at $37.90.

Apollo Medical Price Performance

The stock’s 50-day simple moving average is $35.46 and its 200 day simple moving average is $35.20. The company has a quick ratio of 2.50, a current ratio of 2.50 and a debt-to-equity ratio of 0.36. The company has a market cap of $1.97 billion, a price-to-earnings ratio of 32.06, a PEG ratio of 2.87 and a beta of 0.83.

Apollo Medical (NASDAQ:AMEH) last issued its quarterly earnings results on Monday, August 7th. The company reported $0.28 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.28. The business had revenue of $348.21 million for the quarter, compared to analysts’ expectations of $341.10 million. Apollo Medical had a net margin of 3.95% and a return on equity of 11.00%. On average, equities research analysts anticipate that Apollo Medical Holdings, Inc. will post 1.15 EPS for the current fiscal year.

Institutional Trading of Apollo Medical

Several hedge funds have recently made changes to their positions in AMEH. JPMorgan Chase & Co. lifted its position in shares of Apollo Medical by 21.0% during the first quarter. JPMorgan Chase & Co. now owns 53,559 shares of the company’s stock worth $2,596,000 after purchasing an additional 9,293 shares in the last quarter. Citigroup Inc. lifted its position in shares of Apollo Medical by 12.9% during the first quarter. Citigroup Inc. now owns 32,729 shares of the company’s stock worth $1,587,000 after purchasing an additional 3,734 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in shares of Apollo Medical by 49.9% during the first quarter. PNC Financial Services Group Inc. now owns 1,563 shares of the company’s stock worth $75,000 after purchasing an additional 520 shares in the last quarter. MetLife Investment Management LLC increased its stake in shares of Apollo Medical by 53.6% during the first quarter. MetLife Investment Management LLC now owns 20,211 shares of the company’s stock worth $980,000 after buying an additional 7,056 shares during the period. Finally, Rhumbline Advisers increased its stake in shares of Apollo Medical by 7.5% during the first quarter. Rhumbline Advisers now owns 92,806 shares of the company’s stock worth $4,498,000 after buying an additional 6,484 shares during the period. Institutional investors and hedge funds own 35.88% of the company’s stock.

Apollo Medical Company Profile

Apollo Medical Holdings, Inc, a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.